SpotSense

What SpotSense does

SpotSense, legally Spot Healthcare Solutions Pvt Ltd, is a Bengaluru-based point-of-care diagnostics company that designs and sells the ViewDx portable in-vitro diagnostic analyzer and a portfolio of more than 30 lateral flow assay test kits covering cardiac, liver, thyroid, fertility, cancer, renal, diabetes, and inflammation biomarkers. The ViewDx reader uses proprietary reflectance photometry combined with image capture to deliver lab-equivalent quantitative results within roughly 2-3 minutes, including dual-mode colorimetric and fluorescent detection on v4 hardware, and integrates digitally with laboratory information and electronic health record systems via cross-platform connectivity tools.

The company earns revenue across four streams: one-time hardware sales (the ViewDx at ₹1,22,040), recurring consumable test kit sales at ₹198-₹4,800 per kit, OEM and private-label contract manufacturing plus white-label LFA readout SDKs, and joint feasibility studies and research pilots with partners. SpotSense reaches customers through three concurrent GTM motions: a direct-to-consumer e-commerce storefront at spotsense.in shipping across India and internationally via courier partners, an OEM/embedded motion supplying exclusive contract manufacturing and co-branded products to healthcare partners, and an event-driven joint R&D motion that runs feasibility studies in partner territories. End customers include hospitals, secondary care clinics, field healthcare and outreach settings, standalone labs, emergency and critical care units, and individual patients.

SpotSense operates as a privately held Indian company founded in 2016 with 11-50 employees. No institutional venture or growth-equity financing is disclosed beyond an early 2018 Venture Center program entry; the business appears to be founder-financed and bootstrapped. The company's differentiation rests on its proprietary reader architecture, broad biomarker menu, and OEM/private-label software-plus-hardware platform rather than on patented IP, regulatory exclusivity, or large-scale distribution.

Name

SpotSense

Legal name

Spot Healthcare Solutions Pvt Ltd

Website

https://spotsense.in

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

11–50 employees

Short description

SpotSense is a Bengaluru-based point-of-care diagnostics company selling the ViewDx portable IVD analyzer and 30+ lateral flow assay test kits for cardiac, liver, fertility, cancer, thyroid, renal, diabetes, and inflammation biomarkers to hospitals, clinics, field healthcare settings, and OEM/private-label partners.

Ownership category

akta.pro rank

Headquarters

HQ city

Bangalore

HQ country

India

HQ region

Asia

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Operations, Supply Chain, Personnel, Marketing or Sales, Infrastructure

Revenue model

1. Diagnostic Hardware Devices: Sale of professional-grade diagnostic hardware including the ViewDx portable IVD analyzer and LFA readers. Devices provide the platform for running SpotSense test kits.
2. Diagnostic Test Kits (Consumables): Sale of single-use diagnostic test kits for various biomarkers including liver function, cardiac markers, fertility hormones, cancer markers, and more. Consumables represent recurring revenue tied to device usage.
3. OEM/Private-Label Manufacturing: Contract manufacturing and design partnership services for custom analyzer development, co-branded tests and consumables, and white-label digital solutions.
4. Research Pilots and Joint R&D: Joint feasibility studies and prototype testing services in partner territories, validating next-generation devices for local market needs.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels7 records

Core offering

SpotSense engineers professional-grade point-of-care diagnostic hardware, anchored by the ViewDx portable IVD analyzer, which uses reflectance photometry to deliver lab-equivalent quantitative results within 2–3 minutes. The company sells a broad portfolio of more than 40 single-use lateral flow assay test kits covering cardiac, liver, thyroid, kidney, fertility, cancer, inflammation, diabetes, anemia, and maternal-health biomarkers. It also provides OEM/private-label contract manufacturing, white-label LFA readout SDKs, and integration services for partner LIS and EHR platforms.

Product overview

SpotSense offers a comprehensive point-of-care diagnostics portfolio consisting of the SpotSense ViewDx portable IVD analyzer as the core hardware platform, paired with an extensive range of lateral flow assay (LFA) test kits spanning multiple biomarker categories including cardiac markers (Troponin I, CK-MB, Myoglobin, NT-proBNP), thyroid function (TSH, T4), liver function (SGPT, SGOT, Albumin), reproductive health (FSH, LH, Testosterone, Progesterone, B-HCG, AMH, Prolactin), cancer markers (CEA, Cancer Antigen, CA-125), inflammation (CRP, SAA, IgE), anemia/iron (Ferritin), kidney function (Cystatin C, Beta-2 Microglobulin, MAU), diabetes management (HbA1c, Insulin), and maternal health (PLGF, sFlt-1, Pregnancy tests). The ViewDx analyzer uses reflectance photometry to deliver lab-equivalent accuracy in under 15 minutes, while the company provides cross-platform connectivity services for integration with Laboratory Information Systems (LIS) and Electronic Health Records (EHR). SpotSense also offers white-label SDKs and custom assay development services for OEM/private-label partnerships.

Differentiator

Problem solved

Functional benefit

Brands

• ViewDx: Portable In-Vitro Diagnostic (IVD) Analyzer designed for point of care testing (POCT) in clinics, healthcare centers, labs, and emergency care

Products and services

• SpotSense ViewDx Portable IVD Analyzer A portable in-vitro diagnostic (IVD) analyzer designed for point-of-care testing (POCT) using reflectance photometry technology. Delivers accurate quantitative test results within 2–3 minutes for use in clinics, healthcare centers, labs, and emergency care. Price: ₹1,22,040. Supports colorimetric and fluorescent signal detection on Version 4 devices, passcode-secured access, and image capture-based quantitative readout.
• SpotSense Blood Group Test Kit Rapid LFA test kit for determining human blood groups. Price: ₹1,950.00.
• SpotSense SGPT (ALT) Test Kit Rapid LFA test kit for detection of Serum Glutamic Pyruvic Transaminase (SGPT/ALT) levels, a key liver enzyme biomarker. Price: ₹1,050.00.
• SpotSense Albumin Test Kit Rapid LFA test kit for detection of albumin levels, a biomarker for liver function, kidney health, and nutritional status. Price: ₹3,150.00.
• SpotSense Gastrin-17 Test Kit Rapid LFA test kit for detection of Gastrin-17 levels, a biomarker for evaluating gastric function, chronic atrophic gastritis, and gastric cancer risk. Price: ₹3,150.00.
• SpotSense Beta-2 Microglobulin Test Kit Rapid LFA test kit for detection of Beta-2 Microglobulin levels, a biomarker for kidney function, multiple myeloma, lymphoma, and autoimmune diseases. Price: ₹3,450.00.
• SpotSense Cystatin C Test Kit Rapid LFA test kit for detection of Cystatin C levels, a sensitive biomarker for early kidney dysfunction and chronic kidney disease monitoring. Price: ₹3,150.00.
• SpotSense sFlt-1 Test Kit LFA test kit for detection of soluble fms-like tyrosine kinase-1 (sFlt-1), an anti-angiogenic protein used in preeclampsia prediction. Price: ₹540.00.
• SpotSense PGI/PGII Test Kits Rapid LFA test kits for detection of Pepsinogen I and Pepsinogen II levels, gastric biomarkers for chronic atrophic gastritis and gastric cancer risk screening. Price: ₹2,700.00.
• SpotSense PLGF Test Kit Rapid LFA test kit for detection of Placental Growth Factor (PLGF) levels, used for early diagnosis and monitoring of preeclampsia. Price: ₹1,950.00.
• SpotSense Progesterone Test Rapid LFA test kit for detection of Progesterone hormone levels, important for fertility assessment, pregnancy monitoring, and reproductive health. Price: ₹420.00.
• SpotSense T4 (Thyroxine) Test Kit LFA test kit for detection of Thyroxine (T4) hormone levels, the primary thyroid hormone regulating metabolism, energy balance, and endocrine function. Price: ₹1,800.00.
• SpotSense Rheumatoid Factor (RF) Test Kit Rapid LFA test kit for detection of Rheumatoid Factor antibodies, important for early diagnosis and monitoring of rheumatoid arthritis and autoimmune disorders. Price: ₹1,170.00.
• SpotSense SP10 Test Kit Rapid LFA test kit for detection of SP10 protein in semen samples, a biomarker for male fertility and sperm function. Price: ₹2,250.00.
• SpotSense S100-beta Test Kit Rapid LFA test kit for detection of S100-beta protein levels, a biomarker for brain injury, stroke, neurodegenerative diseases, and certain cancers. Price: ₹4,800.00.
• SpotSense Serum Amyloid A (SAA) Test Kit Rapid LFA test kit for detection of Serum Amyloid A (SAA) levels, an acute-phase biomarker that rises during infections, inflammation, and tissue injury. Price: ₹1,800.00.
• SpotSense Testosterone Test Kit Rapid LFA test kit for detection of Testosterone hormone levels, important for male reproductive health, fertility, muscle function, and hormonal balance. Price: ₹2,100.00.
• SpotSense Cancer Antigen (CA) Test Rapid LFA test kit for detection of cancer antigen (CA) levels in human samples. Price: ₹1,890.00.
• SpotSense IgE (Immunoglobulin E) Test Rapid LFA test kit for detection of Immunoglobulin E (IgE) levels, a biomarker for allergic reactions, asthma, and immune-related conditions. Price: ₹3,000.00.
• SpotSense Carcinoembryonic Antigen (CEA) Test Rapid LFA test kit for detection of Carcinoembryonic Antigen (CEA) levels, a tumor marker for screening, diagnosis, and monitoring of certain cancers. Price: ₹1,620.00.
• SpotSense Prolactin Testing Kit Rapid LFA test kit for detection of Prolactin hormone levels, important for assessing fertility disorders, pituitary function, and reproductive health. Price: ₹1,350.00.
• SpotSense Salivary C-Reactive Protein (CRP) Test Non-invasive LFA test kit for measuring C-Reactive Protein in saliva samples, designed for point-of-care inflammation monitoring. Price: ₹1,170.00.
• SpotSense Salivary Procalcitonin Test Non-invasive LFA test kit for detecting Procalcitonin levels in saliva samples, a biomarker for bacterial infections and sepsis. Price: ₹1,950.00.
• SpotSense Microalbumin (MAU) Test Kit Rapid LFA test kit for detection of microalbumin in urine samples, an early marker of kidney damage, diabetic nephropathy, and hypertension-related complications. Price: ₹3,450.00.
• SpotSense Insulin Test Kit Rapid LFA test kit for detection of insulin levels, essential for assessment of pancreatic function, insulin resistance, and diabetes monitoring. Price: ₹2,850.00.
• SpotSense Heparin Binding Protein (HBP) Test Rapid LFA test kit for detection of Heparin Binding Protein (HBP) levels, used for early identification of sepsis and severe bacterial infections. Price: ₹1,800.00.
• SpotSense B-HCG Test Rapid LFA test kit for detection of Beta-Human Chorionic Gonadotropin (beta-hCG) levels, used for early pregnancy detection and tumor monitoring. Price: ₹2,175.00.
• SpotSense Prostate Specific Antigen (PSA) Test Rapid LFA test kit for detection of Prostate Specific Antigen (PSA) levels, used for screening and monitoring of prostate health and cancer risk. Price: ₹1,620.00.
• SpotSense SGOT (AST) Test Rapid LFA test kit for detection of Serum Glutamic Oxaloacetic Transaminase (SGOT/AST) levels, a biomarker for liver health, heart injury, and muscle damage. Price: ₹198.00.
• SpotSense Creatine Kinase-MB (CK-MB) Test Kit Accurate LFA test kit for detection of Creatine Kinase-MB levels, a cardiac biomarker for confirming acute myocardial infarction and monitoring cardiac muscle damage. Price: ₹2,790.00.
• SpotSense Myoglobin Test Kit Rapid LFA test kit for detection of Myoglobin levels, an early biomarker for acute myocardial infarction and muscle injury used in emergency screening. Price: ₹2,790.00.
• SpotSense Luteinizing Hormone (LH) Test Kit Rapid LFA test kit for detection of Luteinizing Hormone (LH) levels, used to assess ovulation, fertility, and reproductive health. Price: ₹1,350.00.
• SpotSense Ferritin Test Kit Rapid LFA test kit for detection of ferritin levels, an essential biomarker for assessing iron storage, anemia, and related conditions. Price: ₹1,530.00.
• SpotSense Troponin I Test Kit Rapid LFA test kit for detection of cardiac Troponin I levels, a critical biomarker for acute myocardial infarction and cardiac injuries in emergency care. Price: ₹1,620.00.
• SpotSense Follicle Stimulating Hormone (FSH) Test Kit Rapid LFA test kit for detection of Follicle Stimulating Hormone (FSH) levels, a reproductive hormone used to assess fertility, ovarian function, and menopausal status. Price: ₹1,350.00.
• SpotSense NT-proBNP Rapid Test Kit Rapid LFA test kit for detection of N-terminal pro B-type Natriuretic Peptide (NT-proBNP) levels, an important biomarker for heart failure. Price: ₹2,520.00.
• SpotSense Vitamin D Rapid Test Kit Rapid LFA test kit for detection of Vitamin D levels, an essential biomarker for bone health, immunity, and overall wellness. Price: ₹1,890.00.
• SpotSense Anti-Mullerian Hormone (AMH) Test Rapid LFA test kit for detection of Anti-Mullerian Hormone (AMH) levels, a biomarker for assessing ovarian reserve, fertility potential, and reproductive health. Price: ₹1,950.00.
• SpotSense HbA1c Rapid Test Kit Rapid LFA test kit for quantitative detection of HbA1c levels, a biomarker for long-term blood glucose control and diabetes management. Price: ₹1,170.00.
• SpotSense TSH Rapid Test Rapid LFA test kit for qualitative detection of Thyroid Stimulating Hormone (TSH) levels, for point-of-care thyroid disorder screening. Price: ₹1,530.00.
• OEM/Private-Label Contract Manufacturing and Design Services End-to-end OEM/private-label service covering custom analyzer development, custom assay development, co-branded test kits and consumables, white-label LFA readout SDKs for branded smartphone apps, and integration support with partner LIS/EHR systems. Targeted at healthcare companies building private, high-margin branded diagnostics product lines.
• Joint R&D and Research Pilot Services Joint R&D and market validation services conducted in partner territories. Includes feasibility studies, prototype testing, biomarker panel development, and validation of next-generation diagnostic devices for local clinical needs and regulatory requirements.

Quantifiable outcome

• Lab-equivalent accuracy in under 15 minutes
• +2 more outcomes

Segments5 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration2 records

AI capability3 records

Feature7 records

Partnerships

One partnership is on record.

• OEM Partners (Unnamed)coreOEM/ Whitelabel/ Licensing PartnerSpotSense serves as exclusive contract manufacturing and design partner for healthcare companies seeking to build private, high-margin product lines. They provide white-label LFA readout SDKs enabling rapid launch of branded smartphone applications connected to SpotSense hardware data systems. Partners benefit from custom analyzer development, custom assay development, co-branded tests and consumables, and digital solutions for POC manufacturing.

Scale indicators2 records

Recent moves5 records

Expansion highlights5 records

Regional players

• Transasia Bio-Medicals: India's largest IVD company offering a broad portfolio of clinical chemistry, immunoassay, and hematology analyzers and reagents. Regional incumbent competing with SpotSense in Indian hospital and lab diagnostics.
• J Mitra & Co: Indian diagnostics manufacturer specializing in rapid diagnostic test kits (HIV, hepatitis, dengue, etc.) with proprietary reader systems. Direct regional competitor in India's LFA-based diagnostics market.
• Agappe Diagnostics: Indian IVD manufacturer and OEM/contract manufacturing partner offering clinical chemistry reagents and analyzer systems. Comparable India-based competitor with strong OEM/private-label capabilities similar to SpotSense's business model.

Emerging players

• Quotient Limited: Developer of the MosaiQ rapid transfusion diagnostic platform, an automated cartridge-based IVD system for blood banking and serology. Comparable in applying automation and connectivity to lateral-flow style testing workflows.
• Hemex Health: US-based startup developing affordable POC diagnostic readers for global health settings, including LFA readers for hemoglobin and infectious diseases. Comparable emerging player pursuing low-cost quantitative LFA readouts for emerging markets.

Direct peers

• SD Biosensor: South Korea-based manufacturer of LFA-based rapid diagnostic readers (e.g., STANDARD F) with proprietary fluorescent readouts. Direct competitor in the quantitative LFA reader category and a benchmark for SpotSense's dual-mode ViewDx platform.
• Boditech Med: Korean POC diagnostics company offering the AFIAS and ichroma line of LFA readers with broad immunoassay menus including cardiac and inflammatory markers. Directly competes with SpotSense's quantitative LFA platform.

Broad incumbents

• Abbott Point of Care (i-STAT): Abbott's i-STAT system is a handheld POC analyzer for blood diagnostics used in hospitals, emergency rooms, and clinics globally. It is the dominant incumbent in the bedside POC diagnostics category SpotSense targets with ViewDx.
• Trinity Biotech: Ireland-based IVD company with POC immunoassay systems (e.g., Meritas, Premier) covering cardiac and infectious disease biomarkers. Established POC diagnostics competitor with overlapping menu and device model.
• Roche Diagnostics (cobas / Accu-Chek): Roche offers POC and centralized immunoassay solutions (cobas, Accu-Chek) covering cardiac, fertility, and metabolic markers. It is a global IVD incumbent whose menu breadth overlaps significantly with SpotSense's biomarker catalog.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key highlights6 records

Customer concentration

• YouTubeyoutube.com/@spotsense7211
• LinkedInlinkedin.com/company/spotsense-healthcare-private-limited
• Instagraminstagram.com/spotsense.in
• Xx.com/spotsense

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SpotSense